Akero Therapeutics (AKRO) Q3 2025 Earnings

8AugConfirmed
Q4 2024
Q1 2025
Q2 2025
Q3 2025
-1.16
-1.06
-0.96
-0.86

Details

Expected EPS
-0.917119
Actual EPS
-0.86
Surprise EPS
0.06
Surprise Percent
+6.23%

Description

Akero Therapeutics (AKRO) has reported earnings of -0.86 per share for Q3 2025.

0 Comments

Share your thoughts